🧔♂️ A friendly human may check it before it goes live. More news here
General Catalyst-backed Tandem Tech said to near $1b valuation
Healthcare AI startup Tandem Technology Inc. has reached a valuation of US$1 billion, according to sources familiar with the matter.
The New York-based company is raising US$100 million in a funding round led by venture capital firm Accel.
Tandem develops technology to streamline prescription processes, including automating prior authorizations and pharmacy routing, at no cost to providers or patients.
The startup has previously raised US$137 million, with Thrive Capital and General Catalyst among its backers.
General Catalyst led a US$30 million series A round in 2024.
Tandem plans to partner with biopharma firms to accelerate drug development and expects to serve millions of patients in 2026.
The company has not publicly announced the funding or valuation, and representatives did not respond to requests for comment.
🔗 Source: Bloomberg
🧠 Food for thought
Implications, context, and why it matters.
Tandem’s $1 billion valuation warrants scrutiny of its real-world impact
- A $1 billion valuation has been cited, yet measurable results from Tandem’s AI have not been shared publicly.
- “Faster prior authorization turnaround times” have been claimed in a partner testimonial, while numbers such as time-to-therapy reductions or first-pass approval rate gains have not been published by the company or the source 2.
- The operational footprint of Tandem still needs verification.
- Millions of patients are expected to use the service in 2026, but current live deployments or integrations have not been named for payers, pharmacy benefit managers (PBMs, companies that administer prescription drug benefits for health insurers and employers), or major Electronic Health Record (EHR) systems 1.
Standardized prior authorization APIs could expand the infrastructure market beyond AI workflow tools
- Health care technology builders and investors face a new opening as prior authorization standards move forward.
- A technical implementation guide for a standardized Prior Authorization Support application programming interface (API) is already in development, which signals a move away from manual work 3.
- Teams that sell API management or monitoring software can offer products that help payers and health care providers set up these links and keep them running.
- This infrastructure becomes a base layer that AI platforms like Tandem will rely on as they grow.
